News WordPress Theme

Pfizer CEO: Three Covid shots against omicron variant equivalent to two targeting original strains

Pfizer CEO Albert Bourla sits down with CNBC’s Meg Tirrell to break down the company’s latest data, which suggests three doses of its Covid-19 vaccine neutralizes the worrisome omicron variant. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi  Three doses of Pfizer and BioNTech’s vaccine provide a high level of protection against the…

Read More

From Elon Musk to Satya Nadella: CEOs unload shares at record pace

According to InsiderScore, CEOs and insiders have unloaded $69 billion in stocks so far this year, up 80% over the 10-year average. CNBC’s Robert Frank reports. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi  CEOs and corporate insiders have sold a record $69 billion in stock in 2021, as looming tax hikes and…

Read More

What investors should expect from Rivian's upcoming IPO

CNBC’s Phil LeBeau joins ‘Squawk Box’ to break down what investors need to know about electric-vehicle company Rivian’s looming stock market debut. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC » Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic Turn to CNBC TV for the…

Read More

What investors should expect from Rivian's upcoming IPO

CNBC’s Phil LeBeau joins ‘Squawk Box’ to break down what investors need to know about electric-vehicle company Rivian’s looming stock market debut. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC » Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic Turn to CNBC TV for the…

Read More

What investors should expect from Rivian's upcoming IPO

CNBC’s Phil LeBeau joins ‘Squawk Box’ to break down what investors need to know about electric-vehicle company Rivian’s looming stock market debut. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC » Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic Turn to CNBC TV for the…

Read More

GE to split aviation, health care and energy into 3 public companies

CNBC’s David Faber joins ‘Squawk Box’ to report on General Electric’s plan to spin its aviation, health care and energy businesses into three public companies. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi U.S. industrial giant General Electric will split into three companies following years of seeing its stock underperform, the company announced…

Read More

Dr. Scott Gottlieb: End of Covid pandemic in the U.S. is 'in sight'

Dr. Scott Gottlieb, former FDA commissioner, joins ‘Squawk Box’ to react to Pfizer’s Covid-19 antiviral pill, which the company says was highly effective in clinical trials. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi The Covid-19 pandemic could be over in the U.S. by the time President Joe Biden’s workplace vaccine mandates take…

Read More

Dr. Scott Gottlieb: End of Covid pandemic in the U.S. is 'in sight'

Dr. Scott Gottlieb, former FDA commissioner, joins ‘Squawk Box’ to react to Pfizer’s Covid-19 antiviral pill, which the company says was highly effective in clinical trials. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi The Covid-19 pandemic could be over in the U.S. by the time President Joe Biden’s workplace vaccine mandates take…

Read More

Dr. Scott Gottlieb: End of Covid pandemic in the U.S. is 'in sight'

Dr. Scott Gottlieb, former FDA commissioner, joins ‘Squawk Box’ to react to Pfizer’s Covid-19 antiviral pill, which the company says was highly effective in clinical trials. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi The Covid-19 pandemic could be over in the U.S. by the time President Joe Biden’s workplace vaccine mandates take…

Read More